16.02
-0.04 (-0.25%)
-0.04 (-0.25%)
Upgrade to Real-Time
Afterhours (Closed)
Low
15.395
High
26.75
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nektar Therapeutics | NKTR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.04 | -0.25% | 16.02 | 00:00:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.92 | 15.745 | 16.15 | 15.79 | 16.06 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 12.92 | 17.40 | 4.48 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,731 | 611,158 | $ 15.87 | $ 9,696,121 | - | 15.395 - 26.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:53:45 | formt | 100 | $ 16.02 | USD |
Period:
Draw Mode:
Nektar Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.92B | 182.31M | 89.79M | $ 152.92M | $ - | -2.49 | -6.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -87.96k | 2.10% |
Nektar Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NKTR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.37 | 16.70 | 15.745 | 16.15 | 566,217 | -0.35 | -2.14% |
| 1 Month | 17.50 | 17.62 | 15.745 | 16.59 | 744,783 | -1.48 | -8.46% |
| 3 Months | 18.34 | 20.25 | 15.745 | 17.49 | 902,003 | -2.32 | -12.65% |
| 6 Months | 22.94 | 26.75 | 15.745 | 19.86 | 1,016,420 | -6.92 | -30.17% |
| 1 Year | 22.35 | 26.75 | 15.395 | 19.00 | 1,037,768 | -6.33 | -28.32% |
| 3 Years | 50.49 | 69.759 | 13.63 | 27.72 | 1,724,909 | -34.47 | -68.27% |
| 5 Years | 17.40 | 111.36 | 11.41 | 36.35 | 1,879,405 | -1.38 | -7.93% |
Nektar Therapeutics Description
| Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. The company has additional operations facilities in Huntsville, Alabama, and Hyderabad, India. |
